Publication Information

{'id': 'https://openalex.org/W2411569365', 'doi': None, 'title': '[Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].', 'display_name': '[Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].', 'publication_year': 2013, 'publication_date': '2013-07-01', 'ids': {'openalex': 'https://openalex.org/W2411569365', 'mag': '2411569365', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/23961668'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23961668', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5071921086', 'display_name': 'Takashi Imagama', 'orcid': 'https://orcid.org/0000-0001-8509-1850'}, 'institutions': [{'id': 'https://openalex.org/I173915773', 'display_name': 'Yamaguchi University', 'ror': 'https://ror.org/03cxys317', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I173915773']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takashi Imagama', 'raw_affiliation_strings': ['Department of Orthopedic Surgery, Yamaguchi University Graduate School of Medicine.'], 'affiliations': [{'raw_affiliation_string': 'Department of Orthopedic Surgery, Yamaguchi University Graduate School of Medicine.', 'institution_ids': ['https://openalex.org/I173915773']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5083869070', 'display_name': 'Toshihiko Taguchi', 'orcid': 'https://orcid.org/0000-0003-1802-3473'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Toshihiko Taguchi', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.281, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.509784, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 65, 'max': 72}, 'biblio': {'volume': '71', 'issue': '7', 'first_page': '1209', 'last_page': '13'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9915, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9915, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10308', 'display_name': 'Systemic Lupus Erythematosus Research', 'score': 0.9834, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9747, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/discontinuation', 'display_name': 'Discontinuation', 'score': 0.83333707}, {'id': 'https://openalex.org/keywords/adverse-drug-reaction', 'display_name': 'Adverse drug reaction', 'score': 0.478897}], 'concepts': [{'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.9804332}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.8936424}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.834923}, {'id': 'https://openalex.org/C2778715236', 'wikidata': 'https://www.wikidata.org/wiki/Q55622662', 'display_name': 'Discontinuation', 'level': 2, 'score': 0.83333707}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.66791177}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.58479875}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.5720085}, {'id': 'https://openalex.org/C198451711', 'wikidata': 'https://www.wikidata.org/wiki/Q327657', 'display_name': 'Rheumatology', 'level': 2, 'score': 0.5507513}, {'id': 'https://openalex.org/C2777077863', 'wikidata': 'https://www.wikidata.org/wiki/Q170990', 'display_name': 'Arthritis', 'level': 2, 'score': 0.5271002}, {'id': 'https://openalex.org/C2780542314', 'wikidata': 'https://www.wikidata.org/wiki/Q45959', 'display_name': 'Adverse drug reaction', 'level': 3, 'score': 0.478897}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.44742116}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.44511873}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.2729867}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069285', 'descriptor_name': 'Infliximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23961668', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.86, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4247970800', 'https://openalex.org/W4234876404', 'https://openalex.org/W2411569365', 'https://openalex.org/W2165561719', 'https://openalex.org/W2112475478', 'https://openalex.org/W2030855147', 'https://openalex.org/W2015993259', 'https://openalex.org/W2002704741', 'https://openalex.org/W1996208529', 'https://openalex.org/W1836146112'], 'abstract_inverted_index': {'Abundant': [0], 'evidence': [1], 'of': [2, 37, 50, 53, 64, 91], 'infliximab': [3, 81], '(tumor': [4], 'necrosis': [5], 'factor': [6], 'inhibitor)': [7], 'has': [8, 31], 'been': [9, 33], 'collected': [10], 'in': [11], 'rheumatoid': [12], 'arthritis.': [13], 'Infliximab': [14], 'is': [15, 40, 48, 71], 'effective': [16], 'not': [17], 'only': [18], 'for': [19, 26, 78], 'resolving': [20], 'the': [21, 51, 62, 84, 88, 97], 'clinical': [22], 'symptoms,': [23], 'but': [24], 'also': [25, 32], 'preventing': [27], 'joint': [28], 'destruction.': [29], 'It': [30, 70], 'reported': [34], 'that': [35], 'discontinuation': [36], 'this': [38], 'drug': [39, 98], 'possible': [41], 'after': [42], 'attaining': [43], 'low': [44], 'disease': [45], 'activity.': [46], 'This': [47], 'one': [49], 'characteristics': [52], 'infliximab.': [54], 'However,': [55], 'patients': [56, 76], 'should': [57, 99], 'be': [58, 100], 'adequately': [59], 'cautioned': [60], 'against': [61], 'development': [63], 'adverse': [65, 94], 'reactions,': [66], 'such': [67], 'as': [68], 'infections.': [69], 'essential': [72], 'to': [73, 96], 'carefully': [74], 'select': [75], 'eligible': [77], 'treatment': [79], 'with': [80], 'based': [82], 'on': [83], 'guidelines': [85], 'established': [86], 'by': [87], 'Japan': [89], 'College': [90], 'Rheumatology,': [92], 'and': [93, 105], 'reactions': [95], 'prevented': [101], 'or': [102], 'detected': [103], 'early': [104], 'treated': [106], 'promptly.': [107]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2411569365', 'counts_by_year': [{'year': 2015, 'cited_by_count': 1}], 'updated_date': '2024-12-15T03:44:29.943230', 'created_date': '2016-06-24'}